Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boehringer And Anthem Put Stiolto Duo To Real World Test In COPD

Oct 06 2017

• By Emily Hayes

lung illustration

Related Content

Boehringer/WellPoint Outcomes Research To Inform Pradaxa Treatment

Dec 02 2014

Efficacy Studies Not Enough? Consider GSK's Salford Lung Study As New Model

Sep 13 2017

FDA OK's Boehringer's Stiolto Respimat in COPD

May 27 2015

GOLD Pushes LABA/LAMA Class In New COPD Treatment Update

Nov 28 2016

Real-World Evidence: Lessons From GSK's Salford Lung Study

Sep 09 2016

Related Companies

Boehringer Ingelheim GmbH

Anthem Inc.

GSK plc

Novartis AG

AstraZeneca PLC

GSK plc

Additional Topics

Clinical Trials Market Access Market Intelligence Research & Development Commercial Respiratory BioPharmaceutical

More from Respiratory

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window